Therapy in patients at high risk for atherosclerotic cardiovascular disease -: From biological efficacy to disappointing clinical outcomes

被引：0
|
作者：
Fainaru, M [1 ]
机构：
[1] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel
来源：
FREE RADICAL BIOLOGY AND MEDICINE | 2002年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
487
引用
收藏
页码：S186 / S186
页数：1
相关论文
共 50 条
  • [11] Clinical trials of gene therapy for atherosclerotic cardiovascular disease
    Freedman, SB
    CURRENT OPINION IN LIPIDOLOGY, 2002, 13 (06) : 653 - 661
  • [12] Targeting Lipoprotein(a) to reduce residual risk in high risk atherosclerotic cardiovascular disease patients
    Waring, Ashley A.
    Morris, Pamela B.
    REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA, 2023, 52 (02): : 59 - 64
  • [13] Lipoprotein(a)-Associated Residual Atherosclerotic Cardiovascular Disease Risk in Patients with Cardiovascular Disease on Statin Therapy by Diabetes Status
    Zhao, Yanglu
    Sung, Jennifer C.
    Browne, Auris
    Wong, Nathan D.
    DIABETES, 2020, 69
  • [14] Design of a clinical risk calculator for major clinical outcomes in patients with atherosclerotic renovascular disease
    Vassallo, Diana
    Foley, Robert N.
    Kalra, Philip A.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (08) : 1377 - 1384
  • [15] Efficacy and Safety of Alirocumab in High-Risk Patients With Clinical Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from 5 Placebo-Controlled ODYSSEY Trials)
    McCullough, Peter A.
    Ballantyne, Christie M.
    Sanganalmath, Santosh K.
    Langslet, Gisle
    Baum, Seth J.
    Shah, Prediman K.
    Koren, Andrew
    Mandel, Jonas
    Davidson, Michael H.
    AMERICAN JOURNAL OF CARDIOLOGY, 2018, 121 (08): : 940 - 948
  • [16] Lipidomic profile in patients with a very high risk of atherosclerotic cardiovascular disease on PCSK9 inhibitor therapy
    Huang, Kui
    Wen, Xiao-Qin
    Ren, Ning
    Yang, Li
    Gao, Bo
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2021, 22 (02) : 461 - 467
  • [17] ECONOMIC BURDEN OF DIABETIC PATIENTS WITH ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE OR RISK FACTORS FOR ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
    Marcellusi, A.
    Sciattella, P.
    Bini, C.
    Rotundo, M.
    Aimaretti, G.
    Mennini, F. S.
    VALUE IN HEALTH, 2020, 23 : S509 - S509
  • [18] Statins and atherosclerotic cardiovascular outcomes in patients on incident dialysis and with atherosclerotic heart disease
    Shavadia, Jay S.
    Wilson, Jonathan
    Edmonston, Daniel
    Platt, Alyssa
    Ephraim, Patti
    Hall, Rasheeda
    Goldstein, Benjamin A.
    Boulware, L. Ebony
    Peterson, Eric
    Pendergast, Jane
    Scialla, Julia J.
    AMERICAN HEART JOURNAL, 2021, 231 : 36 - 44
  • [19] Comparative Outcomes of Interventions for Peripheral Arterial Disease in Patients With Different Atherosclerotic Cardiovascular Disease Risk Estimates
    Huttler, Joshua
    Jamil, Yasser
    Wu, Zhen
    Slade, Martin
    Ochoa, Cassius I.
    CIRCULATION, 2023, 148
  • [20] Treatment algorithm in patients with type 2 diabetes and atherosclerotic cardiovascular disease or high/very high cardiovascular risk
    Targher, Giovanni
    Byrne, Christopher D.
    EUROPEAN HEART JOURNAL, 2020, 41 (02) : 331 - 331
12345